Gene · 10499
Papers3,077
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,077
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions. | Int J Mol Sci | 2024 | 38256018 | PubTator, text mining | PubMed |
| A Review of CYP-Mediated Drug Interactions: Mechanisms and In Vitro Drug-Drug Interaction Assessment. | Biomolecules | 2024 | 38254699 | PubTator, text mining | PubMed |
| Expression profile analysis of LncRNAs and mRNAs in pre-receptive endometrium of women with polycystic ovary syndrome undergoing in vitro fertilization-embryo transfer. | BMC Med Genomics | 2024 | 38243290 | PubTator, text mining | PubMed |
| Recent developments in sunscreens based on chromophore compounds and nanoparticles. | RSC Adv | 2024 | 38226149 | PubTator, text mining | PubMed |
| Non-canonical regulation of the reactivation of an oncogenic herpesvirus by the OTUD4-USP7 deubiquitinases. | PLoS Pathog | 2024 | 38215174 | PubTator, text mining | PubMed |
| Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme. | Nat Med | 2024 | 38200255 | PubTator, text mining | PubMed |
| [SRF-rearranged cellular perivascular myoid tumor: a clinicopathological analysis of two cases]. | Zhonghua Bing Li Xue Za Zhi | 2024 | 38178749 | PubTator, text mining | PubMed |
| Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions. | Nat Commun | 2024 | 38168093 | PubTator, text mining | PubMed |
| Rhabdomyosarcoma: Updates on classification and the necessity of molecular testing beyond immunohistochemistry. | Hum Pathol | 2024 | 38135061 | PubTator, text mining | PubMed |
| Androgen Receptor-Interacting Proteins in Prostate Cancer Development and Therapy Resistance. | Am J Pathol | 2024 | 38104650 | PubTator, text mining | PubMed |
| Profiling of secondary metabolite and evaluation of anti-diabetic potency of Crotalaria quinquefolia (L): In-vitro, in-vivo, and in-silico approaches. | Saudi Pharm J | 2024 | 38090734 | PubTator, text mining | PubMed |
| NR1D1-rearranged soft tissue tumour: A clinicopathological and molecular analysis of four additional cases. | Histopathology | 2024 | 38084644 | PubTator, text mining | PubMed |
| Acetylation and deacetylation of histone in adipocyte differentiation and the potential significance in cancer. | Transl Oncol | 2024 | 37935080 | PubTator, text mining | PubMed |
| Myxoid epithelioid smooth muscle tumor of the vulva: A distinct entity with MEF2D::NCOA2 gene fusion. | Genes Chromosomes Cancer | 2024 | 37870842 | PubTator, text mining | PubMed |
| CYP1A1 immunohistochemistry is highly specific for angiofibroma of soft tissue among morphological mimics. | Histopathology | 2024 | 37855220 | PubTator, text mining | PubMed |
| Identification of formononetin as the active compound of CR-SR in hepatocellular carcinoma treatment: An integrated approach combining network pharmacology and weighted gene co-expression networks. | Chem Biol Drug Des | 2024 | 37793997 | PubTator, text mining | PubMed |
| Novel NCOA2/3-rearranged low-grade fibroblastic spindle cell tumors: A report of five cases. | Genes Chromosomes Cancer | 2024 | 37724942 | PubTator, text mining | PubMed |
| Detection of mesenchymal chondrosarcoma in pleural effusion with immunocytochemistry and determination of HEY1::NCOA2 fusion by next-generation sequencing on cell block. | Cytopathology | 2024 | 37688410 | PubTator, text mining | PubMed |
| Functional Genomics of Novel Rhabdomyosarcoma Fusion-Oncogenes Using Zebrafish. | Methods Mol Biol | 2024 | 37668903 | PubTator, text mining | PubMed |
| A Case of Uterine Tumor Resembling Ovarian Sex Cord Tumor With Prominent Myxoid Features. | Int J Gynecol Pathol | 2024 | 37406360 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10499/papers?page=6